Papers

2

Total Citations

75

H-Index

2

About

Yeliz Gedik is a pioneering researcher in robotic biomanufacturing and stem cell engineering, whose work is transforming how human pluripotent stem cells (hiPSCs) are cultured and differentiated for therapeutic applications. Her major contributions center on developing high-throughput, automated systems that replace traditional manual cell culture—a process notorious for its variability and labor intensity. In her landmark 2021 study, cited 68 times, Gedik demonstrated a robotic platform capable of scalable self-renewal and functional differentiation of hiPSCs, addressing a critical bottleneck in translating stem cell therapies from lab to clinic. This work, alongside a related 2020 publication (7 citations), establishes her as a leader in integrating robotics with stem cell biology, enabling reproducible, high-yield manufacturing of cells for regenerative medicine. Gedik’s achievements are particularly notable for their potential to accelerate drug screening, disease modeling, and personalized cell therapies, making her research indispensable for students and scientists aiming to bridge engineering and biology. Her innovative approach promises to democratize access to consistent, high-quality stem cell products, marking a significant leap toward automated, cost-effective biomanufacturing.

Research Focus

Key Achievements

2
H-Index
2
Papers
75
Total Citations
38
Avg Citations/Paper
🏆 Most Cited Paper
Robotic high-throughput biomanufacturing and functional differentiation of human pluripotent stem cells
68 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: National Center for Advancing Translational Sciences, National Institutes of Health

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago